NASDAQ

Estrella Immunopharma, Inc. - Warrant (ESLAW)

♥ 573 Thanks from members

Community market perspectives and discussion for Estrella Immunopharma, Inc. - Warrant (NASDAQ: ESLAW).

No chart available for this instrument.

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Estrella Immunopharma ManagementLeadership: Cheng Liu (CEO)Holder: Institutional InvestorsHolder: InsidersCommon Stock Warrants#ESLAW#Estrella Immunopharma#immunotherapy#biotech warrants#NASDAQ stock